N-Desmethylclobazam

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C15H11ClN2O2
Molecular Weight	286.713
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of N-Desmethylclobazam

Structure Search

SMILES

ClC1=CC=C2NC(=O)CC(=O)N(C3=CC=CC=C3)C2=C1

InChI

InChIKey=RRTVVRIFVKKTJK-UHFFFAOYSA-N

InChI=1S/C15H11ClN2O2/c16-10-6-7-12-13(8-10)18(11-4-2-1-3-5-11)15(20)9-14(19)17-12/h1-8H,9H2,(H,17,19)

HIDE SMILES / InChI

Molecular Formula	C15H11ClN2O2
Molecular Weight	286.713
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Patents

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 19:52:24 GMT 2025` Edited by `admin` on `Mon Mar 31 19:52:24 GMT 2025`
Record UNII	MZ4L647O2H
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

NORCLOBAZAM

Preferred Name

English

N-Desmethylclobazam

Common Name

English

8-Chloro-1-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione

Systematic Name

English

7-chloro-5-phenyl-1,5-dihydro-3H-1,5-benzodiazepine-2,4-dione

Common Name

English

CLOBAZAM IMPURITY A [EP IMPURITY]

Common Name

English

1H-1,5-Benzodiazepine-2,4(3H,5H)-dione, 8-chloro-1-phenyl-

Systematic Name

English

CLOBAZAM METABOLITE M9

Common Name

English

DESMETHYLCLOBAZAM

Common Name

English

Code System Code Type Description

ECHA (EC/EINECS)

244-909-2

Created by admin on Mon Mar 31 19:52:24 GMT 2025 , Edited by admin on Mon Mar 31 19:52:24 GMT 2025

PRIMARY

PUBCHEM

89657

Created by admin on Mon Mar 31 19:52:24 GMT 2025 , Edited by admin on Mon Mar 31 19:52:24 GMT 2025

PRIMARY

EPA CompTox

DTXSID40176859

Created by admin on Mon Mar 31 19:52:24 GMT 2025 , Edited by admin on Mon Mar 31 19:52:24 GMT 2025

PRIMARY

RS_ITEM_NUM

1138314

Created by admin on Mon Mar 31 19:52:24 GMT 2025 , Edited by admin on Mon Mar 31 19:52:24 GMT 2025

PRIMARY

CAS

22316-55-8

Created by admin on Mon Mar 31 19:52:24 GMT 2025 , Edited by admin on Mon Mar 31 19:52:24 GMT 2025

PRIMARY

FDA UNII

MZ4L647O2H

Created by admin on Mon Mar 31 19:52:24 GMT 2025 , Edited by admin on Mon Mar 31 19:52:24 GMT 2025

PRIMARY

MESH

C024581

Created by admin on Mon Mar 31 19:52:24 GMT 2025 , Edited by admin on Mon Mar 31 19:52:24 GMT 2025

PRIMARY

Related Record Type Details


					L9DP834D1P

CYTOCHROME P450 2C9

METABOLIC ENZYME -> INHIBITOR

Interaction Type:

WEAK

Qualification:

IC50

Amount:


					2Z7LDE78YX

URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 1A4

METABOLIC ENZYME -> INHIBITOR

Interaction Type:

WEAK

Qualification:

IC50

Amount:


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Interaction Type:

BINDING

Amount:


					FGQ0BCJ2G9

URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 1A6

METABOLIC ENZYME -> INHIBITOR

Interaction Type:

WEAK

Qualification:

IC50

Amount:


					O9NNS94T6B

URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 2B4

METABOLIC ENZYME -> INHIBITOR

Interaction Type:

WEAK

Qualification:

IC50

Amount:


					22ES734693

MULTIDRUG RESISTANCE PROTEIN 1

TRANSPORTER -> SUBSTRATE

Related Record Type Details


					2MRO291B4U

CLOBAZAM

PARENT -> METABOLITE ACTIVE

Amount:

Related Record Type Details


					2MRO291B4U

CLOBAZAM

PARENT -> IMPURITY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Biological Half-life	PHARMACOKINETIC